Real needle-free GLP-1 exists: the Wegovy oral tablet (oral semaglutide 25 mg, FDA-approved December 2025, 13.6% weight loss in the OASIS 4 trial) and experimental microneedle patches from Daewoong Therapeutics (80% bioavailability in a 70-person Phase 1 study, 2028-2030 market estimate)
GLP-1 lawsuits involve allegations that manufacturers of medications such as Ozempic, Wegovy, Mounjaro, Zepbound, and related drugs failed to adequately warn consumers and prescribing physicians about serious health risks associated with these medications
Always verify that the pharmacy is licensed through your state board of pharmacy
Lancet Diabetes endocrinol (2021) 9(10):65362
Plateaus are a documented part of the weight loss journey, especially as you approach your body's natural settling point
P is being seen for falls, which already places her at elevated fracture risk